VectorBuilder
@vectorbuilder.bsky.social
VectorBuilder is a global leader in gene delivery technologies.
Missed last week's seminar?
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
December 19, 2025 at 6:09 PM
Missed last week's seminar?
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable measurement is essential for understanding drug loading, composition, heterogeneity, and stability.
A little holiday surprise showed up under the VectorBuilder tree 🎄
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
December 18, 2025 at 7:49 PM
A little holiday surprise showed up under the VectorBuilder tree 🎄
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
We’re excited to share that VectorBuilder was named LSSM Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
Earlier this year, Dr. Katherine Sadleir and the Vassar lab showed that annexin A6 localizes to dystrophic neurites and reduces neurite burden and phosphorylated tau in AD model mice, supporting further investigation of rA6 to limit Aβ-induced membrane damage.
December 17, 2025 at 9:24 PM
Earlier this year, Dr. Katherine Sadleir and the Vassar lab showed that annexin A6 localizes to dystrophic neurites and reduces neurite burden and phosphorylated tau in AD model mice, supporting further investigation of rA6 to limit Aβ-induced membrane damage.
At VectorBuilder, we're proud to build lasting partnerships in science. Thank you to Dr. Angelina Palacios Muñoz from Universidad de Valparaíso (Chile) for this testimonial. We love to hear how our team has helped and supported your research breakthroughs throughout this year!
December 15, 2025 at 7:16 PM
At VectorBuilder, we're proud to build lasting partnerships in science. Thank you to Dr. Angelina Palacios Muñoz from Universidad de Valparaíso (Chile) for this testimonial. We love to hear how our team has helped and supported your research breakthroughs throughout this year!
Don't miss! Our seminar with Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) starts today!
Join the webinar here:
us06web.zoom.us/webinar/regi...
Join the webinar here:
us06web.zoom.us/webinar/regi...
December 11, 2025 at 3:21 PM
Don't miss! Our seminar with Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) starts today!
Join the webinar here:
us06web.zoom.us/webinar/regi...
Join the webinar here:
us06web.zoom.us/webinar/regi...
We had a great time connecting with you all at #CellBio2025!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
December 10, 2025 at 7:59 PM
We had a great time connecting with you all at #CellBio2025!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
Missed us and our cool swag at Cell Bio? No problem! Reach out to our team and we'll send you our VectorBuilder 2026 calendars on your next order!
Thank you @ascbiology.bsky.social and @embo.org for having us, and see you next year!
Curious to see what it really takes to bring your research to the drug development stage? 🧬
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
December 9, 2025 at 10:17 PM
Curious to see what it really takes to bring your research to the drug development stage? 🧬
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc, as he explored the scientific, financial, and societal drivers behind the process.
New SelectScience article featuring insights from Dr. Alan Griffith, VectorBuilder’s Head of CDMO Operations, on why mechanism of action (MoA)-based potency assays are essential for successful gene therapy development.
A great read for anyone advancing gene therapy programs.
A great read for anyone advancing gene therapy programs.
Mechanism-linked potency assays drive gene therapy success
VectorBuilder’s Alan Griffith explains the value of MoA-reflective potency assays for gene therapy development and the benefits of working with assay specialists like Svar Life Science
www.selectscience.net
December 8, 2025 at 7:22 PM
New SelectScience article featuring insights from Dr. Alan Griffith, VectorBuilder’s Head of CDMO Operations, on why mechanism of action (MoA)-based potency assays are essential for successful gene therapy development.
A great read for anyone advancing gene therapy programs.
A great read for anyone advancing gene therapy programs.
Attending #CellBio2025? Stop by our Booth #307 and chat with our team to learn about our latest offerings and solutions for your research needs. Be sure to also catch our presentation, "Optimizing lentiviral vector design and production for cell and gene therapies" at Board B488. See you there!
December 5, 2025 at 7:22 PM
Attending #CellBio2025? Stop by our Booth #307 and chat with our team to learn about our latest offerings and solutions for your research needs. Be sure to also catch our presentation, "Optimizing lentiviral vector design and production for cell and gene therapies" at Board B488. See you there!
Congrats to Dr. Zinia Mohanta and the McMahon Lab! Their new study shows the first in vivo use of a genetically encoded CEST MRI reporter delivered by rAAV. superCESTide enabled non-invasive, dose-dependent imaging of transgene expression, bringing in vivo gene expression into clear view.
December 4, 2025 at 6:34 PM
Congrats to Dr. Zinia Mohanta and the McMahon Lab! Their new study shows the first in vivo use of a genetically encoded CEST MRI reporter delivered by rAAV. superCESTide enabled non-invasive, dose-dependent imaging of transgene expression, bringing in vivo gene expression into clear view.
Reminder! Join us next week for a seminar with Dr. @Cat Saunders (Senior Applications Specialist at @SPARTA Biodiscovery) introducing a first-in-class, label-free platform for single-particle characterization, SPARTA®.
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
Working in drug delivery, gene therapy, or nanoparticle formulation? Our December Gene Deliver Seminar with SPARTA Biodiscovery is for you!
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
December 3, 2025 at 6:38 PM
Reminder! Join us next week for a seminar with Dr. @Cat Saunders (Senior Applications Specialist at @SPARTA Biodiscovery) introducing a first-in-class, label-free platform for single-particle characterization, SPARTA®.
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
This December, the VectorBuilder team will be going to several key conferences around the world! Don't miss us at the upcoming conferences!
December 2, 2025 at 5:27 PM
This December, the VectorBuilder team will be going to several key conferences around the world! Don't miss us at the upcoming conferences!
On #WorldAIDSDay, we highlight research advancing HIV prevention & treatment.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
December 1, 2025 at 7:36 PM
On #WorldAIDSDay, we highlight research advancing HIV prevention & treatment.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
A study from the Kula-Pacurar lab at Małopolska Centre of Biotechnology introduces a dual-fluorescent HIV-1 reporter system that measures a key step in viral replication & could support discovery of new HIV therapeutics.
The VectorBuilder team is headed to Hobart for the Australasian Neuroscience Society Annual Scientific Meeting! Catch our Territory Manager, Dr. Chee Ho H'ng, and our Associate Director, Dr. Thomas Leung!
November 27, 2025 at 6:08 PM
The VectorBuilder team is headed to Hobart for the Australasian Neuroscience Society Annual Scientific Meeting! Catch our Territory Manager, Dr. Chee Ho H'ng, and our Associate Director, Dr. Thomas Leung!
Working in drug delivery, gene therapy, or nanoparticle formulation? Our December Gene Deliver Seminar with SPARTA Biodiscovery is for you!
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
November 26, 2025 at 4:07 PM
Working in drug delivery, gene therapy, or nanoparticle formulation? Our December Gene Deliver Seminar with SPARTA Biodiscovery is for you!
Register here! us06web.zoom.us/webinar/regi...
Register here! us06web.zoom.us/webinar/regi...
MiniVec™ was created to reduce barriers and fuel new discoveries. We’re honored that Prof. Matthias Stephan and his team trust MiniVec™ to enhance efficiency, improve safety, and stay focused on the science that matters.
Now license fee–free through year-end!
Now license fee–free through year-end!
November 25, 2025 at 6:36 PM
MiniVec™ was created to reduce barriers and fuel new discoveries. We’re honored that Prof. Matthias Stephan and his team trust MiniVec™ to enhance efficiency, improve safety, and stay focused on the science that matters.
Now license fee–free through year-end!
Now license fee–free through year-end!
We’re excited to share that VectorBuilder received the 2025 Bioz Rapid Star Award for our vectors! This reflects the rapid rise in citations from researchers using our tools. Thank you for letting us be part of your discoveries!
November 24, 2025 at 5:09 PM
We’re excited to share that VectorBuilder received the 2025 Bioz Rapid Star Award for our vectors! This reflects the rapid rise in citations from researchers using our tools. Thank you for letting us be part of your discoveries!
Still unsure if MiniVec™ is right for your project?
Here’s a quick look at how antibiotic-free, supplement-free plasmids can streamline your gene delivery pipeline. License fee–free until the end of the year!
Here’s a quick look at how antibiotic-free, supplement-free plasmids can streamline your gene delivery pipeline. License fee–free until the end of the year!
November 21, 2025 at 5:40 PM
Still unsure if MiniVec™ is right for your project?
Here’s a quick look at how antibiotic-free, supplement-free plasmids can streamline your gene delivery pipeline. License fee–free until the end of the year!
Here’s a quick look at how antibiotic-free, supplement-free plasmids can streamline your gene delivery pipeline. License fee–free until the end of the year!
Last call to level up your next experiment and save big! Our Fall promotion wraps up this weekend — don’t miss it.
🍁 Fall into your next big discovery, TODAY!
Get 15% off (max $1,000) on any new quote created Nov 12–23, one-time use only.
🍁Code: VBFall20251112
Get 15% off (max $1,000) on any new quote created Nov 12–23, one-time use only.
🍁Code: VBFall20251112
November 21, 2025 at 5:22 PM
Last call to level up your next experiment and save big! Our Fall promotion wraps up this weekend — don’t miss it.
Congratulations to our customer Jingwei Zhang and the Weinberg Lab, whose recent work reveals how inflammation “awakens” dormant breast cancer cells, pushing them toward metastasis.
One step closer to advancing our understanding and prevention of cancer relapse!
One step closer to advancing our understanding and prevention of cancer relapse!
What causes dormant cancer cells to wake up and start growing and dividing uncontrollably?
A new study from the Weinberg lab at the @whiteheadinstitute.bsky.social has found a unique culprit: inflammation! 💥
Abstract: https://bit.ly/4n75hE8
Press release: https://bit.ly/41KMzK8
A new study from the Weinberg lab at the @whiteheadinstitute.bsky.social has found a unique culprit: inflammation! 💥
Abstract: https://bit.ly/4n75hE8
Press release: https://bit.ly/41KMzK8
November 19, 2025 at 5:11 PM
Congratulations to our customer Jingwei Zhang and the Weinberg Lab, whose recent work reveals how inflammation “awakens” dormant breast cancer cells, pushing them toward metastasis.
One step closer to advancing our understanding and prevention of cancer relapse!
One step closer to advancing our understanding and prevention of cancer relapse!
We were honored to take part in the Cold Spring Harbor Asia Conference (@cshasia.bsky.social) on Immunoreceptor Signaling and Therapeutic Applications, where our Founder and CSO, Dr. Bruce Lahn, contributed to the program.
November 18, 2025 at 5:20 PM
We were honored to take part in the Cold Spring Harbor Asia Conference (@cshasia.bsky.social) on Immunoreceptor Signaling and Therapeutic Applications, where our Founder and CSO, Dr. Bruce Lahn, contributed to the program.
Catch Dr. Morgan Dwyer at the 24th BioPharma Drug Discovery Nexus in Parsippany, New Jersey! Join her talk this Wednesday, Nov 19 at 8:40 AM on "Translating Success: The Importance of Early-Stage Vector Design for Cell and Gene Therapies."
November 17, 2025 at 9:05 PM
Catch Dr. Morgan Dwyer at the 24th BioPharma Drug Discovery Nexus in Parsippany, New Jersey! Join her talk this Wednesday, Nov 19 at 8:40 AM on "Translating Success: The Importance of Early-Stage Vector Design for Cell and Gene Therapies."
🧠 If you’re at #SfN25 and haven’t stopped by yet, come visit us at Booth #729 — the team is here and we still have plenty of colorful VectorBuilder swag and 2026 calendars to brighten your day.
And don’t forget to join us tomorrow for our presentation during the Multiomics Session at 10:45 am 🧬
And don’t forget to join us tomorrow for our presentation during the Multiomics Session at 10:45 am 🧬
November 17, 2025 at 6:36 PM
🧠 If you’re at #SfN25 and haven’t stopped by yet, come visit us at Booth #729 — the team is here and we still have plenty of colorful VectorBuilder swag and 2026 calendars to brighten your day.
And don’t forget to join us tomorrow for our presentation during the Multiomics Session at 10:45 am 🧬
And don’t forget to join us tomorrow for our presentation during the Multiomics Session at 10:45 am 🧬
💙 Today is #WorldDiabetesDay, a reminder of the millions living with this complex disease. Researchers continue to advance diabetes care — from understanding insulin biology to developing innovative therapies. We are proud to support this global effort!
November 14, 2025 at 6:35 PM
💙 Today is #WorldDiabetesDay, a reminder of the millions living with this complex disease. Researchers continue to advance diabetes care — from understanding insulin biology to developing innovative therapies. We are proud to support this global effort!
Heading to #SfN25? Don’t miss our presentation on how our advanced AAV capsid engineering platform has generated novel capsids with unique tissue-targeting capabilities — or stop by our booth to say hi to Croy, Rebecca, Benancio, and Sam. See you Sunday!
November 14, 2025 at 6:01 PM
Heading to #SfN25? Don’t miss our presentation on how our advanced AAV capsid engineering platform has generated novel capsids with unique tissue-targeting capabilities — or stop by our booth to say hi to Croy, Rebecca, Benancio, and Sam. See you Sunday!